Page 187 - PRECONGRESS COURSE 06

Supplementation of luteal phase with hCG after GnRH agonist triggering in low risk for OHSS patients
90 80 70 60 50 40 30 20 10
0
53.3 46.2
1500 IU Humaidan 2006
Clinical pregnancy
36.7 32.9
1500 IU Humaidan 2010
CP GnRH agonist
CP hCG
34.4 28.4
Severe OHSS incidence % 95% CI
Clinical pregnancy % 95% CI
Supplementation of luteal phase with hCG after GnRH agonist triggering in low risk for OHSS patients
25
20
15
10
5
0
Severe OHSS
0.0
1500 IU Humaidan 2006
2.0 0.0
1500 IU Humaidan 2010
OHSS GnRH agonist OHSS hCG
1.6 0.0
1500 IU X2 Humaidan 2013
Page 183 of 258
1500 IU X2 Humaidan 2013
PRECONGRESS COURSE 06 I GENEVA, SWITZERLAND – 2 JULY 2017 187